结局变量,N,治疗效应系数,标准误,95%CI下限,95%CI上限,P值,R²,显著,控制变量,解释
ALT变化,281,0.44618550571259696,1.2719843848896437,-2.0578784056633754,2.9502494170885694,0.7260226565529537,0.06349861970534709,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组ALT变化无显著增加0.45单位
AST变化,281,0.6006508696679693,0.8819083504909041,-1.135498488641158,2.336800227977097,0.4963934422913242,0.06071268368448257,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组AST变化无显著增加0.60单位
肝硬度变化,216,-0.48791478257056514,0.45062265711932964,-1.376238398946276,0.40040883380514586,0.28015802079983276,0.5454885991190702,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组肝硬度变化无显著减少0.49单位
